Science AdvancesNeurosciencePeer-reviewed journal article
Transcriptional signatures of heroin intake and seeking throughout the brain reward circuit
Caleb J. BrowneiD, Rita FutamuraiD, Angelica M. Minier-ToribioiD, Emily M. HicksiD, Aarthi RamakrishnaniD, Freddyson J. Martínez-RiveraiD, Molly S. EstilliD, Arthur GodinoiD, Eric M. PariseiD, Angélica Torres‐BerríoiD, Ashley M. CunninghamiD, Peter J. HamiltoniD, Deena M. WalkeriD, Laura M. HuckinsiD, Yasmin L. HurdiD, Li SheniD, Eric J. NestleriD
Abstract
Opioid use disorder (OUD) looms as one of the most severe medical crises currently facing society. More effective therapeutics for OUD requires in-depth understanding of molecular changes supporting drug-taking and relapse. Recent efforts have helped advance these aims, but studies have been limited in number and scope. Here, we develop a brain reward circuit-wide atlas of opioid-induced transcriptional regulation by combining RNA sequencing (RNAseq) and heroin self-administration in male mice modeling multiple OUD-relevant conditions: acute heroin exposure, chronic heroin intake, context-induced drug-seeking following prolonged abstinence, and heroin-primed drug-seeking (i.e., "relapse"). Bioinformatics analysis of this rich dataset identified numerous patterns of molecular changes, transcriptional regulation, brain-region-specific involvement in various aspects of OUD, and both region-specific and pan-circuit biological domains affected by heroin. Integrating RNAseq data with behavioral outcomes using factor analysis to generate an "addiction index" uncovered novel roles for particular brain regions in promoting addiction-relevant behavior, and implicated multi-regional changes in affected genes and biological processes. Comparisons with RNAseq and genome-wide association studies from humans with OUD reveal convergent molecular regulation that are implicated in drug-taking and relapse, and point to novel gene candidates with high therapeutic potential for OUD. These results outline broad molecular reprogramming that may directly promote the development and maintenance of OUD, and provide a foundational resource to the field for future research into OUD mechanisms and treatment strategies.
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 53
- FWCI
- 6.29
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcriptional alterations in opioid use disorder reveal an interplay between neuroinflammation and synaptic remodeling
Marianne L. Seney, Sam-Moon Kim, … Ryan Wellington Logan·Biological PsychiatryPeer-reviewed·Jun 12, 2021
- A computational strategy for finding novel targets and therapeutic compounds for opioid dependence
Xiaojun Wu, Siwei Xie, … Wei Wu·PLoS ONEPeer-reviewed·Nov 7, 2018
- Histone H3 dopaminylation in ventral tegmental area underlies heroin-induced maladaptive plasticity
Sasha L. Fulton, Swarup Mitra, … Ian S. Maze·NeuropsychopharmacologyPeer-reviewed·Jan 29, 2022
- Molecular rhythm alterations in prefrontal cortex and nucleus accumbens associated with opioid use disorder
Xiangning Xue, Wei Zong, … Ryan Wellington Logan·Translational PsychiatryPeer-reviewed·Mar 26, 2022
- Functional genomic mechanisms of opioid action and opioid use disorder: a systematic review of animal models and human studies
Camille Falconnier, Alba Caparros-Roissard, … Pierre-Éric Lutz·Molecular PsychiatryPeer-reviewed·Sep 15, 2023
- A multi-symptomatic model of heroin use disorder in rats reveals distinct behavioral profiles and neuronal correlates of heroin vulnerability versus resiliency
Brittany N. Kuhn, Nazzareno Cannella, … Peter W. Kalivas·American Journal of PsychiatryPeer-reviewed·Jan 15, 2025